XML 74 R19.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Business Segments | 12 Months Ended
--- | ---
Dec. 31, 2013
Segment Reporting [Abstract] |
Business Segments | Business Segments. The Company has four reportable segments: Apex, Oxford, Life Sciences, and Physician. The Apex segment provides mission-critical IT operations professionals for contract, contract-to-hire and permanent placement positions to Fortune 1000 and mid-market clients across the United States, and offers consulting services for other select project-based needs. Apex provides staffing and services support for companies from all major industries, including financial services, business services, consumer and industrials, technology, healthcare, government services, and communications. The Oxford segment provides high-end contract and direct placement services of information technology and engineering professionals with expertise in specialized information technology; software and hardware engineering; and mechanical, electrical, validation and telecommunications engineering fields. The Life Sciences segment provides contract, contract-to-permanent and direct placement services of laboratory and scientific professionals to the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical and environmental industries. These contract staffing specialties include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, food scientists, regulatory affairs specialists, lab assistants and other skilled scientific professionals. The Physician segment provides contract and direct placement physicians to healthcare organizations. The Physician segment works with nearly all medical specialties, placing locum tenens physicians in hospitals, community-based practices, and federal, state and local facilities. During 2013, the Company sold its Nurse Travel line of business and most of the Allied Healthcare line of business. See Note 4 Discontinued Operations for further information. As a result of these sales, the Healthcare segment no longer exists and Health Information Management ("HIM"), formerly included in the Healthcare Segment, is included in the Oxford Segment and unallocated corporate expenses are separately disclosed in order to align with the revised internal reporting package reviewed by the Chief Operating Decision Maker. All prior periods have been restated to conform to this presentation. The Company’s management evaluates the performance of each segment primarily based on revenues, gross profit and operating income. The information in the following table is derived directly from the segments’ internal financial reporting used for corporate management purposes. The following table represents revenues, gross profit, operating income, amortization and total assets by reportable segment (in thousands):
| Year ended December 31, 2013
| Apex |  | Oxford |  | Life Sciences |  | Physician |  | Corporate |  | Total
Revenues | $ | 942,463 |  |  | $ | 412,189 |  |  | $ | 171,518 |  |  | $ | 105,827 |  |  | $ | — |  |  | $ | 1,631,997 |
Gross Profit | 258,150 |  |  | 143,334 |  |  | 56,308 |  |  | 30,614 |  |  | — |  |  | 488,406 |
Operating income | 76,971 |  |  | 58,990 |  |  | 28,354 |  |  | 8,852 |  |  | (49,199 | ) |  | 123,968 |
Amortization | 19,524 |  |  | 965 |  |  | 429 |  |  | 742 |  |  | 91 |  |  | 21,751 |
Total assets (1) | 656,733 |  |  | 365,118 |  |  | 128,824 |  |  | 110,519 |  |  | — |  |  | 1,261,194 |
| Year ended December 31, 2012
| Apex |  | Oxford |  | Life Sciences |  | Physician |  | Corporate |  | Total
Revenues | $ | 508,743 |  |  | $ | 363,765 |  |  | $ | 162,799 |  |  | $ | 102,679 |  |  | $ | — |  |  | $ | 1,137,986 |
Gross Profit | 140,669 |  |  | 127,895 |  |  | 55,874 |  |  | 31,455 |  |  | — |  |  | 355,893 |
Operating income | 36,416 |  |  | 56,289 |  |  | 25,632 |  |  | 9,998 |  |  | (47,154 | ) |  | 81,181 |
Amortization | 15,665 |  |  | 437 |  |  | 807 |  |  | 817 |  |  | 290 |  |  | 18,016 |
Total assets (1) | 642,594 |  |  | 235,099 |  |  | 150,696 |  | (2) | 86,074 |  |  | — |  |  | 1,114,463 |
| Year ended December 31, 2011
| Apex |  |  | Oxford |  |  | Life Sciences |  |  | Physician |  |  | Corporate |  | Total
Revenues | $ | — |  |  | $ | 279,643 |  |  | $ | 155,324 |  |  | $ | 80,617 |  |  | $ | — |  |  | $ | 515,584 |
Gross Profit | — |  |  | 99,187 |  |  | 52,643 |  |  | 25,858 |  |  | — |  |  | 177,688 |
Operating income | — |  |  | 37,676 |  |  | 24,883 |  |  | 6,699 |  |  | (30,625 | ) |  | 38,633 |
Amortization | — |  |  | 821 |  |  | 901 |  |  | 415 |  |  | 209 |  |  | 2,346 |
Total assets (1) | — |  |  | 221,690 |  |  | 119,563 |  | (2) | 86,014 |  |  | — |  |  | 427,267 |
______ |  |  |  |  |  |  |  |  |  |  |
(1) As of end of the year. (2) Life Sciences total assets as of December 31, 2012 and 2011 include assets related to the Healthcare segment, which were sold and included in discontinued operations in 2013. Historically, the Company has not reported Life Science and Healthcare segments' total assets separately as the operations were largely centralized. The Company operates internationally, with operations in the United States, Europe, Canada, China, Australia, and New Zealand. The following table represents revenues by geographic location (in thousands):
|  | Year Ended December 31,
|  | 2013 |  | 2012 |  | 2011
Revenues: |  |  |  |  |  |
Domestic |  | $ | 1,552,322 |  |  | $ | 1,060,217 |  |  | $ | 447,453 |
Foreign |  | 79,675 |  |  | 77,769 |  |  | 68,131 |
|  | $ | 1,631,997 |  |  | $ | 1,137,986 |  |  | $ | 515,584 |
The following table represents long-lived assets by geographic location (in thousands):
|  | December 31,
|  | 2013 |  | 2012 |  | 2011
Long-lived Assets: |  |  |  |  |  |
Domestic |  | $ | 45,061 |  |  | $ | 40,062 |  |  | $ | 19,078 |
Foreign |  | 2,856 |  |  | 2,006 |  |  | 1,033 |
|  | $ | 47,917 |  |  | $ | 42,068 |  |  | $ | 20,111 |

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 131 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration